Testing effectiveness (Phase 2)Study completedNCT01188967
What this trial is testing
Effectiveness of GSK598809, a Selective D3 Antagonist, Added to CBT and NRT for Smoking Cessation and Relapse Prevention
Who this might be right for
Nicotine Dependence
Massachusetts General Hospital 84